Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

NET 2Gastrointestinal 2Endocrine 2Dermatologic 1

Conditions

Colorectal Neoplasms 317Rectal Neoplasms 235Stomach Neoplasms 209Pancreatic Neoplasms 137Colonic Neoplasms 94Neoplasm Metastasis 60Esophageal Neoplasms 57Neoplasms 40Biliary Tract Neoplasms 39Cholangiocarcinoma 31Carcinoma, Hepatocellular 30Gallbladder Neoplasms 29Breast Neoplasms 28Adenocarcinoma 22Bile Duct Neoplasms 21Locally Advanced Rectal Cancer 20Adenocarcinoma Of Esophagus 20Gastrointestinal Neoplasms 18Liver Neoplasms 17Esophageal Squamous Cell Carcinoma 17Colorectal Cancer Metastatic 15Carcinoma, Non-Small-Cell Lung 12Anus Neoplasms 12Parkinson Disease 4, Autosomal Dominant Lewy Body 11Digestive System Neoplasms 7Carcinoma 7Advanced Gastric Cancer 7Squamous Cell Carcinoma of Head and Neck 6Ovarian Neoplasms 6Klatskin Tumor 6

Interventions

lanreotide 2Temozolomide 2Capecitabine 2zimberelimab 1veliparib 1pembrolizumab 1ganitumab 1conatumumab 1arginyllysine 1Sunitinib 1Rose Bengal 1Quality of Life 1Patient Reported Outcome Measures 1Octreotide 1Molecular Diagnostic Techniques 1Immunotherapy 1Everolimus 1Drug Therapy 1Biological Therapy 1Bevacizumab 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoid Tumor × Capecitabine × Gastrointestinal × Clear all
NCT02831179 2017-09-28

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Vanderbilt-Ingram Cancer Center

Phase 1 Withdrawn
DermatologicEndocrineGastrointestinalNET

Non functioning pancreatic endocrine tumor, Adrenal Cortex Neoplasms, Carcinoid Tumor, Vipoma, Glucagonoma, Insulinoma, Pheochromocytoma, Somatostatinoma, Zollinger-Ellison Syndrome, Carcinoma, Merkel Cell, Carcinoma, Medullary, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2a, Multiple Endocrine Neoplasia Type 2b

NCT00869050 2016-07-25

Capecitabine and Temozolomide for Neuroendocrine Cancers

Columbia University

Phase 2 Completed
41 enrolled 9 charts
EndocrineGastrointestinalNET

Carcinoid Tumor, Vipoma, Pancreatic Neoplasms, Pheochromocytoma, Somatostatinoma, Zollinger-Ellison Syndrome, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡